| Title: |
Tumor lysis syndrome following trastuzumab and pertuzumab for metastatic breast cancer: a case report. |
| Authors: |
Baudon, Céline; Duhoux, François; Sinapi, Isabelle; Canon, Jean-Luc |
| Contributors: |
UCL - SSS/IREC/MIRO - Pôle d'imagerie moléculaire, radiothérapie et oncologie |
| Source: |
Journal of Medical Case Reports, Vol. 10, no.1, p. 178 (2016) |
| Publisher Information: |
BioMed Central Ltd. |
| Publication Year: |
2016 |
| Collection: |
DIAL@USL-B (Université Saint-Louis, Bruxelles) |
| Description: |
Tumor lysis syndrome is a rare and potentially fatal complication of oncologic treatments, especially in solid tumors. To the best of our knowledge, tumor lysis syndrome has never been reported after trastuzumab and pertuzumab combination therapy. Knowledge of risk factors and active prevention proceedings is of utmost importance to avoid fatal outcomes. |
| Document Type: |
article in journal/newspaper |
| Language: |
English |
| Relation: |
boreal:174876; http://hdl.handle.net/2078.1/174876; info:pmid/27312594 |
| DOI: |
10.1186/s13256-016-0969-5 |
| Availability: |
http://hdl.handle.net/2078.1/174876; https://doi.org/10.1186/s13256-016-0969-5 |
| Rights: |
info:eu-repo/semantics/openAccess |
| Accession Number: |
edsbas.5CDB31BD |
| Database: |
BASE |